Neovascular (Wet) Age-Related Macular Degeneration
19 clinical trials · Condition
◉ Watch Neovascular (Wet) Age-Related Macular Degeneration
| Record | Firm | Date |
|---|---|---|
| Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration (NCT05439629) | Bio-Thera Solutions | 2022-07-07 |
| Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (NCT06184360) | Novartis Pharmaceuticals | 2022-05-31 |
| 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration (NCT05197270) | 4D Molecular Therapeutics | 2021-12-09 |
| Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration (NCT04126317) | Regeneron Pharmaceuticals | 2019-11-04 |
| A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration (NCT04857177) | Chong Kun Dang Pharmaceutical | 2018-10-19 |
| Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications (NCT04847895) | Novartis Pharmaceuticals | 2015-06-01 |
Track Neovascular (Wet) Age-Related Macular Degeneration automatically
Every clearance here is in the API, with alerts when new ones post.